Filing Details

Accession Number:
0000950170-24-005388
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-18 16:15:19
Reporting Period:
2024-01-16
Accepted Time:
2024-01-18 16:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH Pharmaceutical Preparations (2834) 200299725
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752827 C. Daniel Martin C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-16 1,624 $14.47 47,660 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was to cover tax liabilities in the vesting of restricted stock units.